Article
FHL1 as a prognostic biomarker and therapeutic target in acute myeloid leukemia
2023-05-11
Abstract excerpt
Acute myeloid leukemia (AML) has a poor prognosis and high heterogeneity. Most leukemias are caused by environmental factors interacting with the cell’s genetic material, but treatment is still dominated by cell cycle drugs. Therefore, there is an urgent need to find reliable biomarkers. Based on the Gene Expression Omnibus database, Kaplan–Meier survival analysis and univariate Cox regression analysis were used t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 99a3dfa6-1491-5659-a377-aa48e3dfbfea
- DOI
- 10.21203/rs.3.rs-2854959/v1
